Your new experience awaits. Try the new design now and help us make it even better

REVIEW article

Front. Surg.

Sec. Visceral Surgery

Volume 12 - 2025 | doi: 10.3389/fsurg.2025.1608467

This article is part of the Research TopicThe Evolving Role of Liver Transplantation for the treatment of Malignant Tumors: Current Perspectives and Future DirectionsView all 3 articles

The Evolving Role of Liver Transplantation for Metastatic Colorectal Cancer: Current Perspectives and Future Directions

Provisionally accepted
  • University of California, San Diego, La Jolla, California, United States

The final, formatted version of the article will be published soon.

Liver transplantation is increasingly being explored as a treatment option for select patients with metastatic colorectal cancer (mCRC). Historically, transplantation for mCRC was abandoned due to poor long-term outcomes and high recurrence rates. However, recent advancements in patient selection, immunosuppressive strategies, and donor organ availability have led to a renewed interest in this approach. Studies have demonstrated that highly selected patients undergoing liver transplantation can achieve significantly improved survival rates compared to those receiving standard systemic therapies. The implementation of Model for End-Stage Liver Disease (MELD) exception points, improved donor preservation techniques such as machine perfusion, and the growing role of living donor liver transplantation have further supported its feasibility. As research continues, liver transplantation may emerge as a crucial component of a multidisciplinary strategy for treating colorectal liver metastases, offering a select group of patients a chance at prolonged survival and improved quality of life.

Keywords: Metastatic colorectal cancer, Hepatic metastasis, Liver Transplantation, MELD Exception, Machine perfusion

Received: 09 Apr 2025; Accepted: 25 Jun 2025.

Copyright: © 2025 Bendersky, Olaso and Schnickel. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Gabriel T Schnickel, University of California, San Diego, La Jolla, 92093, California, United States

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.